Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$11.6B |
| 2 |
NVIDIA
NVDA
|
+$4.91B |
| 3 |
Microsoft
MSFT
|
+$4.44B |
| 4 |
Amazon
AMZN
|
+$3.61B |
| 5 |
Visa
V
|
+$2.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$1.81B |
| 2 |
Applovin
APP
|
+$1.68B |
| 3 |
Palantir
PLTR
|
+$1.32B |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$1.23B |
| 5 |
Marvell Technology
MRVL
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.5% |
| 2 | Financials | 13.58% |
| 3 | Consumer Discretionary | 10.94% |
| 4 | Healthcare | 10% |
| 5 | Industrials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Radiant Logistics
RLGT
$386M
| $17.2M | ﹤0.01% |
2,565,216
+177,990
| +7% | +$1.23M |
|
2652
SES AI
SES
$203M
| $17.2M | ﹤0.01% |
7,847,316
+608,676
| +8% | +$347K |
|
|
ACRE
2653
Ares Commercial Real Estate
ACRE
$236M
| $17.2M | ﹤0.01% |
2,917,578
-64,886
| -2% | -$437K |
|
|
SMC
2654
Summit Midstream
SMC
$426M
| $17.1M | ﹤0.01% |
453,304
| – | – |
|
|
RVNC
2655
DELISTED
Revance Therapeutics, Inc.
RVNC
| $17.1M | ﹤0.01% |
5,625,091
-108,608
| -2% | -$473K |
|
2656
iShares Core S&P 500 ETF
IVV
$872B
| $17.1M | ﹤0.01% |
29,048
+804
| +3% | +$476K |
|
2657
Lufax Holding
LU
$1.35B
| $17.1M | ﹤0.01% |
7,143,366
+70,181
| +1% | +$194K |
|
|
NNE
2658
Nano Nuclear Energy
NNE
$854M
| $17.1M | ﹤0.01% |
685,619
+662,287
| +2,839% | +$15M |
|
2659
Fate Therapeutics
FATE
$286M
| $17M | ﹤0.01% |
10,333,033
-71,090
| -0.7% | -$179K |
|
2660
Allogene Therapeutics
ALLO
$649M
| $17M | ﹤0.01% |
8,000,692
-327,007
| -4% | -$806K |
|
2661
Rigel Pharmaceuticals
RIGL
$681M
| $17M | ﹤0.01% |
1,012,931
+27,640
| +3% | +$530K |
|
|
STKL
2662
DELISTED
SunOpta
STKL
| $17M | ﹤0.01% |
2,207,838
+71,116
| +3% | +$503K |
|
2663
AMC Global Media
AMCX
$492M
| $17M | ﹤0.01% |
1,715,833
+39,581
| +2% | +$350K |
|
2664
First Bank
FRBA
$464M
| $16.9M | ﹤0.01% |
1,202,830
-52,023
| -4% | -$762K |
|
2665
Titan Machinery
TITN
$396M
| $16.9M | ﹤0.01% |
1,193,202
+4,955
| +0.4% | +$71.7K |
|
2666
Spok Holdings
SPOK
$228M
| $16.8M | ﹤0.01% |
1,048,161
-6,020
| -0.6% | -$95.3K |
|
2667
NRC Health Common Stock
NRC
$432M
| $16.8M | ﹤0.01% |
952,664
-33,706
| -3% | -$639K |
|
2668
Vanda Pharmaceuticals
VNDA
$307M
| $16.8M | ﹤0.01% |
3,506,287
-125,002
| -3% | -$600K |
|
2669
Tyra Biosciences
TYRA
$1.9B
| $16.8M | ﹤0.01% |
1,207,765
-37,643
| -3% | -$683K |
|
2670
Southern First Bancshares
SFST
$591M
| $16.7M | ﹤0.01% |
421,300
+1,249
| +0.3% | +$50K |
|
2671
Kodiak Sciences
KOD
$2.6B
| $16.7M | ﹤0.01% |
1,682,209
-2,920
| -0.2% | -$16.8K |
|
|
TECX
2672
Tectonic Therapeutic
TECX
$529M
| $16.7M | ﹤0.01% |
361,048
-81,766
| -18% | -$3.46M |
|
2673
Matrix Service
MTRX
$326M
| $16.7M | ﹤0.01% |
1,391,821
-3,304
| -0.2% | -$40.5K |
|
2674
Gray Television
GTN
$415M
| $16.6M | ﹤0.01% |
5,273,238
-57,023
| -1% | -$266K |
|
2675
RBB Bancorp
RBB
$448M
| $16.5M | ﹤0.01% |
807,176
+5,484
| +0.7% | +$127K |
|
Similar funds
Vanguard Group's Q4 2024 Portfolio in Review
As of Q4 2024, Vanguard Group held 4,397 positions worth $5.74T, up 2.8% from $5.58T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.4%. Vanguard Group opened 46 new positions and exited 103, leaving the 4,397-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2024 buy was Primo Brands: 15,315,211 shares worth $471M.
- Vanguard Group added most to Apple in Q4 2024, an estimated $11.6B increase.
- Vanguard Group's biggest Q4 2024 reduction was Applovin, cutting an estimated $1.68B.
- Vanguard Group fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $1.81B.
- Vanguard Group's ten largest holdings make up 29% of its $5.74T portfolio in Q4 2024.
- Vanguard Group opened 46 new positions and closed 103 in Q4 2024.
- Vanguard Group's portfolio value rose 2.8% quarter-over-quarter to $5.74T.
Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.